{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:50:17Z","timestamp":1771494617871,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","amjmedsci.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.amjms.2024.07.016","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T17:46:45Z","timestamp":1720633605000},"page":"648-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Meta-analysis of renin angiotensin aldosterone modulators mitigating atrial fibrillation risk in hypertensive patients"],"prefix":"10.1016","volume":"368","author":[{"given":"Arankesh","family":"Mahadevan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushmitha","family":"Garikipati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Vanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dakshin Meenashi","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Thompson-Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafisa","family":"Reyaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalaivani","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinishant","family":"Rajarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhayashri","family":"Dhavapalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharshana Prem","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Advait","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupak","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.amjms.2024.07.016_bib0001","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the american heart association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.amjms.2024.07.016_bib0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2125.2008.03234.x","article-title":"The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS","volume":"66","author":"Novo","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.016_bib0003","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MJT.0b013e31804beb59","article-title":"Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis","volume":"15","author":"Jibrini","year":"2008","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.amjms.2024.07.016_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2459\/JCM.0b013e3283640ff7","article-title":"Atrial fibrillation in essential hypertension: an issue of concern","volume":"15","author":"Zhao","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"10","key":"10.1016\/j.amjms.2024.07.016_bib0005","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1540-8159.2004.00645.x","article-title":"The role of angiotensin receptor blockers and\/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials","volume":"27","author":"Madrid","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.amjms.2024.07.016_bib0006","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.111.019927","article-title":"Antiarrhythmic drug therapy for atrial fibrillation","volume":"125","author":"Zimetbaum","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.amjms.2024.07.016_bib0007","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.122.19459","article-title":"Atrial fibrillation detection and management in hypertension","volume":"80","author":"Gawalko","year":"2023","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.amjms.2024.07.016_bib0008","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1074248415619490","article-title":"Effects of RAAS blockers on atrial fibrillation prophylaxis: an updated systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Chaugai","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.amjms.2024.07.016_bib0009","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2362.2010.02460.x","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis","volume":"41","author":"Huang","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.amjms.2024.07.016_bib0010","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ajh.2009.33","article-title":"Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population","volume":"22","author":"Heckbert","year":"2009","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.016_bib0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2012.02.009","article-title":"Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials","volume":"165","author":"Khatib","year":"2013","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.amjms.2024.07.016_bib0012","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/europace\/euv021","article-title":"Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials","volume":"17","author":"Emdin","year":"2015","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.amjms.2024.07.016_bib0013","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/HYPERTENSIONAHA.111.202309","article-title":"Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients","volume":"61","author":"Du","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.016_bib0014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.fjc.0000193808.99773.28","article-title":"Losartan and prevention of atrial fibrillation recurrence in hypertensive patients","volume":"47","author":"Fogari","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"10.1016\/j.amjms.2024.07.016_bib0015","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/ajh.2008.217","article-title":"Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation","volume":"21","author":"Fogari","year":"2008","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.amjms.2024.07.016_bib0016","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/clc.21994","article-title":"Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size","volume":"35","author":"Fogari","year":"2012","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.amjms.2024.07.016_bib0017","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1470320312443909","article-title":"A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients","volume":"13","author":"Galzerano","year":"2012","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"9192","key":"10.1016\/j.amjms.2024.07.016_bib0018","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"issue":"9153","key":"10.1016\/j.amjms.2024.07.016_bib0019","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.amjms.2024.07.016_bib0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/jhh.2016.95","article-title":"Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis","volume":"31","author":"Horio","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"20","key":"10.1016\/j.amjms.2024.07.016_bib0021","doi-asserted-by":"crossref","first-page":"e3721","DOI":"10.1097\/MD.0000000000003721","article-title":"Angiotensin-receptor blocker, angiotensin-converting enzyme inhibitor, and risks of atrial fibrillation: a nationwide cohort study","volume":"95","author":"Hsieh","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.amjms.2024.07.016_bib0022","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/hr.2014.104","article-title":"Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study","volume":"37","author":"Jong","year":"2014","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.016_bib0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2004.03.056","article-title":"Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation","volume":"44","author":"L'Allier","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.amjms.2024.07.016_bib0024","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cjco.2021.04.014","article-title":"Effect of perindopril on atrial fibrillation recurrence and burden: results of the canadian trial of atrial fibrillation (CTAF)-2","volume":"3","author":"Rivard","year":"2021","journal-title":"CJC Open."},{"issue":"2","key":"10.1016\/j.amjms.2024.07.016_bib0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-152-2-201001190-00005","article-title":"Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study","volume":"152","author":"Schaer","year":"2010","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.amjms.2024.07.016_bib0026","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial","volume":"26","author":"Schmieder","year":"2008","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.amjms.2024.07.016_bib0027","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.016_bib0028","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12872-022-02580-2","article-title":"Impact of renin-angiotensin-aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.amjms.2024.07.016_bib0029","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jjcc.2017.07.010","article-title":"Study on the effect of irbesartan on atrial fibrillation recurrence in kumamoto: atrial fibrillation suppression Trial (SILK study)","volume":"71","author":"Yamabe","year":"2018","journal-title":"J Cardiol"},{"issue":"4","key":"10.1016\/j.amjms.2024.07.016_bib0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/europace\/euq439","article-title":"Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study)","volume":"13","author":"Yamashita","year":"2011","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.amjms.2024.07.016_bib0031","doi-asserted-by":"crossref","first-page":"475","DOI":"10.7555\/JBR.29.20140149","article-title":"Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials","volume":"29","author":"Zhao","year":"2015","journal-title":"J Biomed Res"},{"issue":"21","key":"10.1016\/j.amjms.2024.07.016_bib0032","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.amjms.2024.07.016_bib0033","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2024.07.016_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6628469","article-title":"Angiotensin receptor blocker and calcium channel blocker preventing atrial fibrillation recurrence in patients with hypertension and atrial fibrillation: a meta-analysis","volume":"2021","author":"Ma","year":"2021","journal-title":"Cardiovasc Ther"},{"issue":"9689","key":"10.1016\/j.amjms.2024.07.016_bib0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjms.2024.07.016_bib0036","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10654-022-00914-0","article-title":"Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","volume":"38","author":"Aune","year":"2023","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.amjms.2024.07.016_bib0037","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/FJC.0b013e3182a094a1","article-title":"Renin-angiotensin system inhibitors prevent the recurrence of atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"62","author":"Han","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.amjms.2024.07.016_bib0038","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/1755-5922.12073","article-title":"Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis","volume":"32","author":"Pan","year":"2014","journal-title":"Cardiovasc Ther."},{"issue":"15","key":"10.1016\/j.amjms.2024.07.016_bib0039","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Investigators","year":"2008","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.amjms.2024.07.016_bib0040","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/01.CIR.101.22.2612","article-title":"Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation","volume":"101","author":"Nakashima","year":"2000","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.amjms.2024.07.016_bib0041","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0735-1097(03)00464-9","article-title":"Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation","volume":"41","author":"Kumagai","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.016_bib0042","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jelectrocard.2006.04.001","article-title":"Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs","volume":"40","author":"Li","year":"2007","journal-title":"J Electrocardiol"},{"issue":"22","key":"10.1016\/j.amjms.2024.07.016_bib0043","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","article-title":"Atrial remodeling and atrial fibrillation: recent advances and translational perspectives","volume":"63","author":"Nattel","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.amjms.2024.07.016_bib0044","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjms.2024.07.016_bib0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/FJC.0000000000000281","article-title":"Autonomic remodeling: how atrial fibrillation begets atrial fibrillation in the first 24 H","volume":"66","author":"Zhang","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.amjms.2024.07.016_bib0046","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.hrthm.2011.12.023","article-title":"Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle","volume":"9","author":"Yu","year":"2012","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.016_bib0047","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/HCO.0b013e32834dc4e8","article-title":"Neural mechanisms of atrial fibrillation","volume":"27","author":"Park","year":"2012","journal-title":"Curr Opin Cardiol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296292401351X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296292401351X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T03:41:58Z","timestamp":1731469318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296292401351X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S000296292401351X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2024.07.016","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of renin angiotensin aldosterone modulators mitigating atrial fibrillation risk in hypertensive patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2024.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}